Æ

Bruyère Health Research Institute

Neil ThomasNeil Thomas

MD, FRCPC, MSc

 

Affiliate Investigator


Assistant Professor, Neurology

Department of Medicine, University of Ottawa
Member

University of Ottawa Brain and Mind Research Institute
Member

University of Ottawa Music and Health Research Institute

About:

Dr. Neil Thomas is a Cognitive and Behavioral Neurologist at the Bruyère Memory Program, an Assistant Professor of Neurology, Department of Medicine, University of Ottawa and an Affiliate Investigator, Bruyère Health Research Institute in Ottawa, Ontario, Canada. He holds a BSc and MSc in Neuroscience from Queen’s University. He completed his MD and neurology residency training at the University of Ottawa, and a Fellowship in Geriatric Neurology at the Oregon Health and Science University. He is a member of the American Academy of Neurology, the International Society to Advance Alzheimer Research and Treatment, the AGE-WELL National Innovation Hub in Sensors and Analytics for Monitoring Mobility and Memory, and the Consortium of Canadian Centres for Clinical Cognitive Research.


Dr. Thomas’s primary research interests are around the use of home-based technologies and digital biomarkers to evaluate individuals with cognitive impairment, as well as developing and evaluating non-pharmacological intervention and activity programs for individuals with mild cognitive impairment and dementia. He is also interested in how these technologies could be used to objectively measure time and effort related to caregiving activities and the impact this has on caregiver burden.


Research Interests:

Cognitive impairment and dementia, home-based technology and digital biomarkers, caregiver burden.


Select Publications:

Thomas M, Henderson D, Trudel C, Thomas N. (2023). Usability of a community-based dementia resource website: mixed methods study. JMIR Aging.


Thomas NW, Beattie Z, Riley T, Hofer S, Kaye J. (2021). Home-based assessment of cognition and health measures: The Collaborative Aging Research Using Technology (CART) initiative and international collaborations. IEEE Instrumentation & Measurement Magazine.


Thomas NWD, Beattie Z, Marcoe J, Wright K, Sharma N, Mattek N, Dodge H, Wild K, Kaye J. (2020). An ecologically valid, longitudinal, and unbiased assessment of treatment efficacy in Alzheimer Disease (the EVALUATE-AD trial): Proof-of-concept study. JMIR Research Protocols.


Thomas NWD, Lindauer A, Kaye J. (2019). EVALUATE-AD and Tele-STAR: Novel methodologies for assessment of caregiver burden in a telehealth caregiver intervention – a case study. Dementia and Geriatric Cognitive Disorders.


Contact:

nthomas@bruyere.org

 

Learn more at www.sam3.ca 

 

accreditation seal